A SYNdemic BASed INtervention for MSM With High Risk Behavior: Design of a Randomized Controlled Trial

The purpose of this randomized controlled intervention study at the STI outpatient clinic of Amsterdam is to answer the following questions : Does a personalised behaviour intervention comprising of targeted in-depth screening on mental health problems and drug use and, in case identified, subsequent linkage to care increase help seeking behaviour, and decrease risk behaviour in MSM who are at high risk for STIs and HIV?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Risk Behavior Behavior Chemically-Induced Disorders Communicable Diseases Disease Attributes Genital Diseases Infections Mental Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms Risk-Taking Sexually Transmitted Diseases Substance-Related Disorders Urogenital Diseases

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

STI Clinic, Public Health Service Amsterdam

Amsterdam, Netherlands

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

MSM
Sufficient understanding of Dutch or English and
2 STIs in the last 24 months or a PEP treatment for HIV negative MSM

Exclusion criteria

Men will be excluded if they are not able to complete follow-up or otherwise deemed by clinic staff to be unsuited for participation.

Treatment and study plan

Screening and feedback

Behavioral

Screening via questionnaires on mental health problems and feedback on the questionnaires

Primary outcomes

Help seeking behavior

Time frame: one year

Does a personalised behaviour intervention comprising of targeted in depth screening on mental health problems and drug use and linkage to care increase help seeking behaviour among MSM who are at high risk for STIs and HIV.

Secondary outcomes

Risk behavior

Time frame: one year

Does a behaviour intervention comprising of targeted in depth screening on mental health problems and drug use and linkage to care decrease STI prevalence and risky sex (i.e. condom use/ number of partners/ number of unsafe partners/ amount anal sex/ recreational drug use/ stop visiting the STI clinic).

Sponsors and collaborators

Lead sponsor

Public Health Service of Amsterdam

Other Gov

Registry information

Official study title

A SYNdemic BASed Co-located Linkage to Care INtervention for Men Who Have Sex With Men With High Risk Behavior: Design of a Randomized Controlled Trial

Acronym: SYNBASIN

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Aug 9, 2016
Registry last updated: Jan 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed